+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Serum & Plasma Market by Component (Plasma, Serum), Product Type (Instruments, Kits, Reagents), Application, End User, Technique, Distribution Channel - Global Forecast 2025-2030- Product Image
Human Serum & Plasma Market by Component (Plasma, Serum), Product Type (Instruments, Kits, Reagents), Application, End User, Technique, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Human Serum & Plasma Market by Component (Plasma, Serum), Product Type (Instruments, Kits, Reagents), Application, End User, Technique, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6124436
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The human serum and plasma market has undergone significant evolution driven by advancements in diagnostic technology, personalized medicine, and a deeper understanding of immunological pathways. Growing emphasis on precision therapeutics and biomarker discovery has fueled demand for high-quality biological specimens. As clinical laboratories and research centers invest in sophisticated analytical tools, the quality requirements and traceability of serum and plasma samples have become paramount.

Emerging applications in cell therapy manufacturing and vaccine development further underscore the critical role of plasma-derived proteins and serum-based growth factors. Simultaneously, regulatory scrutiny has intensified, with agencies worldwide implementing stricter guidelines for donor screening, manufacturing practices, and cold chain logistics. This confluence of technological innovation and regulatory complexity has reshaped procurement strategies for hospitals, academic institutions, diagnostic laboratories, and biopharmaceutical companies.

Looking ahead, strategic collaborations between component suppliers, instrument vendors, and research organizations are set to redefine supply chain resilience. By integrating real-time analytics and blockchain-based traceability, stakeholders can optimize sample integrity, reduce waste, and ensure compliance across diverse geographies. These core driving forces highlight the market’s shift toward data-driven quality assurance and collaborative ecosystems.

Charting the Pivotal Technological and Collaborative Shifts Driving Innovation in the Global Serum and Plasma Domain

Over the past decade, transformative advancements have reconfigured the human serum and plasma landscape, marked by the rise of high-throughput immunoassays and multiplex platforms. New generation mass spectrometry instruments now deliver unprecedented sensitivity in proteomic profiling, enabling earlier disease detection and therapeutic monitoring. Concurrently, the integration of artificial intelligence algorithms into laboratory workflows has accelerated data interpretation, reducing time-to-result and enhancing diagnostic accuracy.

These shifts have been complemented by the growing adoption of point-of-care testing devices capable of analyzing plasma markers in decentralized settings. As urban and rural healthcare providers seek rapid, on-site diagnostics, demand for compact, cost-effective instruments has surged. In parallel, open innovation models have fostered cross-industry partnerships, bringing together reagent manufacturers, instrument developers, and software providers to co-create end-to-end solutions.

Such collaborative networks, combined with modular kit formats and plug-and-play reagents, are transforming traditional lab operations. Instead of monolithic systems, laboratories now deploy agile, interoperable platforms that scale according to sample throughput. Ultimately, these transformative shifts underscore a broader movement toward decentralized diagnostics, personalized profiling, and seamless integration across the serum and plasma value chain.

Assessing the Far-Reaching Implications of 2025 U.S. Tariff Adjustments on Serum and Plasma Supply Chains

In 2025, the United States implemented cumulative tariff adjustments affecting a broad spectrum of serum and plasma components, instruments, kits, and reagents. These incremental duties have elevated input costs for domestic manufacturers, prompting strategic realignments of supply chains. Some producers have responded by relocating critical assembly operations to tariff-exempt territories or sourcing key reagents from alternative regions to mitigate financial impact.

For diagnostic laboratories and biopharma companies, the increased expense of imported instrumentation and consumables has necessitated a thorough re-evaluation of procurement policies. Tier-two suppliers offering competitive pricing structures have gained traction, although concerns around long-term reliability and technical support persist. Furthermore, end users are adopting more rigorous vendor qualification frameworks, emphasizing total cost of ownership rather than upfront pricing alone.

Despite these headwinds, the tariff-driven environment has accelerated domestic capacity building for plasma fractionation and vial filling services. Regional partnerships between manufacturers and contract research organizations have emerged to share infrastructure, reduce overhead, and sustain product availability. Moving forward, organizations that proactively optimize their sourcing strategies and cultivate multi-regional collaborations will be best positioned to absorb tariff pressures and maintain consistent supply.

Uncovering Critical Segmentation Drivers That Reveal How Diverse Components and Techniques Shape Market Dynamics

The human serum and plasma market comprises diverse segments that collectively define demand patterns and service requirements. Based on component, end users prioritize serum or plasma depending on diagnostic or therapeutic application. When viewed through the lens of product type, laboratories allocate budgets across instruments, kits, reagents, and associated support services to maintain operational flexibility. Application segmentation reveals that diagnostics-particularly in cardiology, infectious diseases, neurology, and oncology-drive significant consumption, while research endeavors and emerging therapeutics continue to expand. End users span academic institutes, diagnostic laboratories, hospitals, and research laboratories, each with unique workflows and compliance considerations. The choice of analytical technique further refines market demand, with chromatography, flow cytometry, immunoassay, mass spectrometry, and western blot platforms representing distinctive capabilities in sensitivity, throughput, and multiplexing. Lastly, distribution channels-comprising offline procurement through direct vendor relationships or online marketplaces-shape accessibility, turnaround times, and cost optimization strategies. By integrating these dimensions, stakeholders can align product development, marketing investments, and technical support to meet evolving laboratory needs and regional regulatory requirements.

Analyzing Distinct Regional Trends Across Americas, Europe Middle East & Africa, and Asia-Pacific That Influence Market Adoption

Regional markets for human serum and plasma exhibit distinct trends driven by healthcare infrastructure, regulatory frameworks, and research priorities. In the Americas, leading academic hospitals and biopharma hubs concentrate on advanced proteomics and cell therapy research, fueling demand for cutting-edge reagents and high-capacity instruments. Meanwhile, the Europe, Middle East & Africa region balances stringent regulatory oversight with growing investment in precision diagnostics, positioning several countries as hotspots for collaborative research consortia. Across Asia-Pacific, rapid healthcare modernization and expanding clinical trial activity have accelerated demand for cost-effective consumables and decentralized testing platforms. This region also benefits from government initiatives supporting domestic reagent manufacturing and cold-chain logistics improvements. Collectively, these regional insights underscore the importance of localized strategies-ranging from tailored technical support networks to region-specific product configurations-to capture growth opportunities and ensure regulatory compliance in a fragmented global landscape.

Exploring How Pioneering Company Collaborations and Innovative Service Models Are Redefining Competitive Dynamics

Leading companies in the human serum and plasma ecosystem are differentiating through innovation, strategic partnerships, and comprehensive service offerings. Major instrument manufacturers are expanding geographic footprints by establishing regional technical centers and offering modular platform upgrades that cater to evolving laboratory demands. Simultaneously, reagent suppliers are investing in proprietary formulations to enhance assay sensitivity and reduce background noise, while kit developers focus on streamlined workflows and automation compatibility. Contract research and manufacturing organizations are forging alliances with academic institutions to accelerate preclinical validation of new biomarkers. Together, these collaborative efforts are reshaping competitive dynamics. Firms that integrate digital support tools-such as remote diagnostics, predictive maintenance, and virtual training-are gaining an edge by minimizing downtime and optimizing resource utilization. As market leaders continue to consolidate specialized capabilities, smaller niche players are finding opportunities in customized reagent development and localized distribution partnerships, fostering a balanced ecosystem of global and regional expertise.

Establishing a Strategic Framework for Supplier Diversification, Digital Enablement, and Collaborative R&D to Enhance Market Resilience

Industry leaders must adopt a proactive stance to navigate evolving market complexities. First, diversifying supplier portfolios by engaging both global and regional partners will mitigate supply disruptions and tariff-related cost increases. Moreover, implementing integrated digital platforms for inventory management and remote system diagnostics will enhance operational resilience and reduce unplanned downtime. To drive adoption, organizations should prioritize co-development agreements with academic and clinical research centers, ensuring early visibility into emerging biomarkers and therapeutic targets. Equally important is investing in comprehensive training programs that upskill laboratory personnel on advanced techniques such as high-resolution mass spectrometry and flow cytometry automation. Additionally, aligning product roadmaps with regional regulatory trends-such as streamlined approval pathways in emerging markets-can accelerate time-to-market for new assays and instrument upgrades. By centering strategies on supplier diversification, digital enablement, collaborative R&D, and regulatory alignment, industry players can secure sustainable growth and maintain a competitive foothold.

Detailing a Comprehensive Multisource Methodology Combining Primary Expert Interviews, Secondary Data Analysis, and Validation Protocols

The research methodology integrates a multi-faceted approach to guarantee robustness and reliability. Primary insights were gathered through interviews with laboratory directors, procurement managers, and R&D heads across hospitals, diagnostic laboratories, academic institutions, and biopharma firms. These qualitative discussions informed understanding of procurement cycles, instrument upgrade preferences, and technique adoption rates. Secondary research encompassed peer-reviewed journals, regulatory filings, and corporate white papers to capture recent technological breakthroughs and policy developments. Market segmentation was validated by cross-referencing supplier catalogs, clinical trial registries, and patent filings, ensuring precise categorization across component, product type, application, end user, technique, and distribution channel. Regional insights drew from government healthcare budgets, import-export data, and regional regulatory databases. Finally, internal data modeling applied trend analysis and scenario-based projections to stress-test key assumptions. This blended methodology ensures that conclusions and recommendations reflect both empirical evidence and forward-looking industry trends.

Summarizing Strategic Imperatives Highlighting Innovation, Supply Chain Resilience, and Regional Nuances in Serum and Plasma Markets

In summary, the human serum and plasma market is at a pivotal juncture characterized by technological innovation, regulatory evolution, and shifting supply chain paradigms. Cutting-edge analytical platforms and AI-driven workflows are redefining diagnostic and research capabilities, while tariff adjustments are prompting strategic realignments in sourcing strategies. The nuanced segmentation landscape and distinct regional characteristics underscore the importance of targeted approaches for product portfolios and market entry tactics. Key companies are differentiating through digital service enhancements, collaborative R&D, and specialized reagent development. To capitalize on these dynamics, stakeholders must fortify supply chain resilience, invest in digital enablement, and foster strategic partnerships that align with emerging therapeutic and diagnostic priorities. By integrating these insights, organizations can navigate complexity, seize growth opportunities, and deliver impactful solutions that advance patient care and scientific discovery.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Component
    • Plasma
    • Serum
  • Product Type
    • Instruments
    • Kits
    • Reagents
    • Services
  • Application
    • Diagnostics
      • Cardiology
      • Infectious Diseases
      • Neurology
      • Oncology
    • Research
    • Therapeutics
  • End User
    • Academic Institutes
    • Diagnostic Laboratories
    • Hospitals
    • Research Laboratories
  • Technique
    • Chromatography
    • Flow Cytometry
    • Immunoassay
    • Mass Spectrometry
    • Western Blot
  • Distribution Channel
    • Offline
    • Online
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • CSL Limited
  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Octapharma AG
  • Biotest AG
  • Bio Products Laboratory Limited
  • Kedrion S.p.A.
  • LFB S.A.
  • Sanquin Plasma Products B.V.
  • Shanghai RAAS Blood Products Co., Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of pathogen inactivation technologies in plasma-derived therapies to enhance safety
5.2. Increasing utilization of large-scale plasma fractionation facilities driven by global immunoglobulin demand
5.3. Emerging recombinant albumin alternatives reducing reliance on human plasma sources and driving innovation
5.4. Expansion of dried plasma products for military and emergency medicine applications to improve field logistics
5.5. Intensifying focus on donor recruitment initiatives in emerging markets to meet rising plasma collection requirements
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Serum & Plasma Market, by Component
8.1. Introduction
8.2. Plasma
8.3. Serum
9. Human Serum & Plasma Market, by Product Type
9.1. Introduction
9.2. Instruments
9.3. Kits
9.4. Reagents
9.5. Services
10. Human Serum & Plasma Market, by Application
10.1. Introduction
10.2. Diagnostics
10.2.1. Cardiology
10.2.2. Infectious Diseases
10.2.3. Neurology
10.2.4. Oncology
10.3. Research
10.4. Therapeutics
11. Human Serum & Plasma Market, by End User
11.1. Introduction
11.2. Academic Institutes
11.3. Diagnostic Laboratories
11.4. Hospitals
11.5. Research Laboratories
12. Human Serum & Plasma Market, by Technique
12.1. Introduction
12.2. Chromatography
12.3. Flow Cytometry
12.4. Immunoassay
12.5. Mass Spectrometry
12.6. Western Blot
13. Human Serum & Plasma Market, by Distribution Channel
13.1. Introduction
13.2. Offline
13.3. Online
14. Americas Human Serum & Plasma Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Human Serum & Plasma Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Human Serum & Plasma Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. CSL Limited
17.3.2. Grifols, S.A.
17.3.3. Takeda Pharmaceutical Company Limited
17.3.4. Octapharma AG
17.3.5. Biotest AG
17.3.6. Bio Products Laboratory Limited
17.3.7. Kedrion S.p.A.
17.3.8. LFB S.A.
17.3.9. Sanquin Plasma Products B.V.
17.3.10. Shanghai RAAS Blood Products Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. HUMAN SERUM & PLASMA MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC HUMAN SERUM & PLASMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC HUMAN SERUM & PLASMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. HUMAN SERUM & PLASMA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. HUMAN SERUM & PLASMA MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. HUMAN SERUM & PLASMA MARKET: RESEARCHAI
FIGURE 28. HUMAN SERUM & PLASMA MARKET: RESEARCHSTATISTICS
FIGURE 29. HUMAN SERUM & PLASMA MARKET: RESEARCHCONTACTS
FIGURE 30. HUMAN SERUM & PLASMA MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMAN SERUM & PLASMA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY WESTERN BLOT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HUMAN SERUM & PLASMA MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS HUMAN SERUM & PLASMA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES HUMAN SERUM & PLASMA MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 103. CANADA HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 104. CANADA HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 105. CANADA HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. CANADA HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. CANADA HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. CANADA HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. CANADA HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 110. CANADA HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 111. CANADA HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. CANADA HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. CANADA HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 114. CANADA HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 115. CANADA HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. CANADA HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. MEXICO HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 118. MEXICO HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 119. MEXICO HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. MEXICO HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. MEXICO HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. MEXICO HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 124. MEXICO HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 125. MEXICO HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. MEXICO HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. MEXICO HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. MEXICO HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. GERMANY HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 190. GERMANY HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 191. GERMANY HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. GERMANY HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. GERMANY HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. GERMANY HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. GERMANY HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 196. GERMANY HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 197. GERMANY HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. GERMANY HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. GERMANY HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 201. GERMANY HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. GERMANY HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. FRANCE HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 204. FRANCE HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 205. FRANCE HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. FRANCE HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. FRANCE HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. FRANCE HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. FRANCE HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 210. FRANCE HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 211. FRANCE HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. FRANCE HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. FRANCE HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 214. FRANCE HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 215. FRANCE HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. FRANCE HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. ITALY HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 232. ITALY HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 233. ITALY HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 234. ITALY HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 235. ITALY HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. ITALY HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. ITALY HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 238. ITALY HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 239. ITALY HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. ITALY HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. ITALY HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 242. ITALY HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 243. ITALY HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. ITALY HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. SPAIN HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 246. SPAIN HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 247. SPAIN HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. SPAIN HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. SPAIN HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. SPAIN HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. SPAIN HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 252. SPAIN HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 253. SPAIN HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. SPAIN HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. SPAIN HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 256. SPAIN HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 257. SPAIN HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. SPAIN HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 284. SAUDI ARABIA HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. SAUDI ARABIA HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. SOUTH AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 298. SOUTH AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. SOUTH AFRICA HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. DENMARK HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 302. DENMARK HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 303. DENMARK HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 304. DENMARK HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 305. DENMARK HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. DENMARK HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. DENMARK HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 308. DENMARK HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 309. DENMARK HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. DENMARK HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. DENMARK HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 312. DENMARK HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 313. DENMARK HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. DENMARK HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. NETHERLANDS HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 322. NETHERLANDS HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 323. NETHERLANDS HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. NETHERLANDS HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. NETHERLANDS HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 326. NETHERLANDS HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 327. NETHERLANDS HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. NETHERLANDS HUMAN SERUM & PLASMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. QATAR HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 330. QATAR HUMAN SERUM & PLASMA MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 331. QATAR HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 332. QATAR HUMAN SERUM & PLASMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 333. QATAR HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 334. QATAR HUMAN SERUM & PLASMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 335. QATAR HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 336. QATAR HUMAN SERUM & PLASMA MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 337. QATAR HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. QATAR HUMAN SERUM & PLASMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. QATAR HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 340. QATAR HUMAN SERUM & PLASMA MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 341. QATAR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Human Serum & Plasma market report include:
  • CSL Limited
  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Octapharma AG
  • Biotest AG
  • Bio Products Laboratory Limited
  • Kedrion S.p.A.
  • LFB S.A.
  • Sanquin Plasma Products B.V.
  • Shanghai RAAS Blood Products Co., Ltd.

Related Reports

Cell-Free RNA Isolation & Extraction Kits Market by Technology (Magnetic Bead, Spin Column), Product (Automated Extraction Kits, Manual Extraction Kits), Application, End User, Sample Type, Sales Channel - Global Forecast 2025-2030 - Product Image

Cell-Free RNA Isolation & Extraction Kits Market by Technology (Magnetic Bead, Spin Column), Product (Automated Extraction Kits, Manual Extraction Kits), Application, End User, Sample Type, Sales Channel - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Sialic Acid Colorimetric Assay Kit Market by Product Type (Plate Based Kits, Reagent Sets, Strip Based Kits), Application (Academic Research, Disease Diagnosis, Drug Development), End User, Sample Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Sialic Acid Colorimetric Assay Kit Market by Product Type (Plate Based Kits, Reagent Sets, Strip Based Kits), Application (Academic Research, Disease Diagnosis, Drug Development), End User, Sample Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Transferrin Detection Kit Market by Assay Format (Clia, Elisa, Fia), Application (Clinical Diagnostics, Point of Care Testing, Research Use), End User, Sample Type - Global Forecast 2025-2030 - Product Image

Transferrin Detection Kit Market by Assay Format (Clia, Elisa, Fia), Application (Clinical Diagnostics, Point of Care Testing, Research Use), End User, Sample Type - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Albumin Market Report and Forecast 2025-2034 - Product Image

Albumin Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Goettingen Minipig Blood Products Market by Product Type (Plasma, Platelets, Serum), Application (Hematology Profiling, Immunology Research, Preclinical Research), End User - Global Forecast 2025-2030 - Product Image

Goettingen Minipig Blood Products Market by Product Type (Plasma, Platelets, Serum), Application (Hematology Profiling, Immunology Research, Preclinical Research), End User - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.